J. Ribamar Costa Jr

Showing 1-9 of 9 articles

Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries

Caixeta A, Campos C, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, Costa Jr J, Onuma Y, van Geuns R, Bartorelli A, Colombo A, Tamburino C, Serruys P, Abizaid A

September 20, 2019 | 10.4244/EIJ-D-16-00796

Coronary interventions

One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials

Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys P

November 20, 2016 | 10.4244/EIJV12I10A206

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Perin M, Seth A, Botelho R, Serruys P

June 19, 2015 | 10.4244/EIJY15M05_06

First-in-man assessment of the InSeal VCD, a novel closure device for large puncture accesses

Kambara A, Bastos Metzger P, Costa Jr J, Moreira S, Penner A, Sousa A, Sousa J, Grube E, Abizaid A

April 20, 2015 | 10.4244/EIJV10I12A242

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

Abizaid A, Costa Jr J, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong W-F, Sudhir K, Serruys P

April 20, 2015 | 10.4244/EIJV10I12A243

Renal sympathetic denervation and ventricular arrhythmias: a case of electrical storm with multiple renal arteries

Staico R, Armaganijan L, Moreira D, Medeiros P, Melo J, Lopes R, Costa Jr J, Abizaid A

May 20, 2014 | 10.4244/EIJV10I1A25

Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents

Costa Jr J, Abizaid A, Sousa A, Siqueira D, Chamié D, Feres F, Costa R, Staico R, Maldonado G, Centemero M, Tanajura L, Viana R, Chaves Á, Abizaid An, Sousa J

June 27, 2012 | 10.4244/EIJV8I2A36

Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis

Costa Jr J, Sousa A, Moreira A, Alves da Costa R, Cano M, Maldonado G, Campos Neto C, Jardim C, Pavanello R, Sousa J

September 30, 2009

Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice

Feres R, Andrade P, Costa R, Costa Jr J, Abizaid A, Staico R, Tanajura L, Siqueira D, Maia J, Lasave L, Sousa A, Sousa J

August 14, 2009

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print: OCT findings in ESR

Jincheng Guo et al.

February 24, 2021

Consolidating the value of the standardised ARC-HBR definition

Giuseppe Gargiulo et al.

February 24, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This weeks JAA's: IVUS Guidewire Locations During Retrograde CTO, TF-TAVI endovascular closing and more..

February 16, 2021

The Year in Review

M. Lunardi et al.

January 22, 2021

Valvular disease